Skip to content

Management of orthodontic pain

Comparative effect of Ketoprofen and Benzocaine chewing gums in reducing orthodontic pain

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014041416466N3
Enrollment
30
Registered
2014-06-27
Start date
2013-09-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

orthodontic pain. Factors influencing health status and contact with health services

Interventions

Intervention 1: ketoprofen(Keto) chewing gum was manufatured with 75mg ketoprufen in R& D department of Minoo industrial company under the consultant pharmacologist. The chewing gum consists of gumbas
Treatment - Drugs
Placebo
ketoprofen(Keto) chewing gum was manufatured with 75mg ketoprufen in R& D department of Minoo industrial company under the consultant pharmacologist. The chewing gum consists of gumbase,sorbitol,Xylit
Benzocain chewing gum (Benzo) chewing gum was manufatured with 20% benzocain in R& D department of Minoo industry company under the consultant pharmacologist. The chewing gum consists ofgumbase,sorbit
Placebo chewing gum chewing gum was manufatured in R& D department of Minoo industry company under the consultant pharmacologist. The chewing gum consists ofgumbase,sorbitol,Xylitol,malnitol,aspartam

Sponsors

Shahid Beheshti Universiy of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 25 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: participants, in good general health without any reported systematic diseases; no concurrent use of analgesics and anti-inflammatory drugs; feel pain more than 50 according to VAS after previous appointment; caries-free dentition with healthy periodontium and without any endodontic problems in the posterior part of the mouth; crowding between 6-8mm and stage of TX in levelling and alignment stage. Patients will be excluded from the study if they used analgesics and anti-inflammatory drugs during the study, did not complete the questionnaire, did not use or improperly used benzocaine or ketoprofen chewing gums.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: 2 h, 6h, 24h, day2(10am and 6 pm), day3(10am and 6 pm) and day7(10 am and 6 pm). Method of measurement: 100 scores visual analogue scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSara Yousefinia

Shahid Beheshti Universiy of Medical Sciences

yousefiniasara@gmail.com+98 21 2990 2304

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026